Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Heptinstall

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Prostaglandins & Other Lipid Mediators|November 25, 2010
PGE1 and PGE2 modify platelet function through different prostanoid receptorsDavid Iyú, Madlen Jüttner, Jackie R Glenn, et al.
Vascular Pharmacology|December 19, 2017
UDP-sugars activate P2Y<sub>14</sub> receptors to mediate vasoconstriction of the porcine coronary arteryZainab S B Abbas, M Liaque Latif, Natalia Dovlatova, et al.
Platelets|February 21, 2018
How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?Susan C Fox, Jane A May, Natalia Dovlatova, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Critical Reviews in Food Science and Nutrition|February 24, 2009
Chocolate, lifestyle, and healthFrancesco Visioli, Herwig Bernaert, Roberto Corti, et al.
Stroke Research and Treatment|June 21, 2017
Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic AttackPhilip M Bath, Jane May, Katie Flaherty, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 17, 2015
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388), Kailash Krishnan, Maia Beridze, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 5, 2016
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trialPhilip Mw Bath, Jason P Appleton, Maia Beridze, et al.
Health Technology Assessment (Winchester, England)|September 5, 2018
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCTPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Prostaglandins & Other Lipid Mediators|November 25, 2010
PGE1 and PGE2 modify platelet function through different prostanoid receptorsDavid Iyú, Madlen Jüttner, Jackie R Glenn, et al.
Vascular Pharmacology|December 19, 2017
UDP-sugars activate P2Y<sub>14</sub> receptors to mediate vasoconstriction of the porcine coronary arteryZainab S B Abbas, M Liaque Latif, Natalia Dovlatova, et al.
Platelets|February 21, 2018
How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?Susan C Fox, Jane A May, Natalia Dovlatova, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Critical Reviews in Food Science and Nutrition|February 24, 2009
Chocolate, lifestyle, and healthFrancesco Visioli, Herwig Bernaert, Roberto Corti, et al.
Stroke Research and Treatment|June 21, 2017
Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic AttackPhilip M Bath, Jane May, Katie Flaherty, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 17, 2015
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388), Kailash Krishnan, Maia Beridze, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 5, 2016
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trialPhilip Mw Bath, Jason P Appleton, Maia Beridze, et al.
Health Technology Assessment (Winchester, England)|September 5, 2018
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCTPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.
Pageof 6